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doi:10.1Objective: The study objective was to examine the late results of mitral valve repair with chordal replacement
with polytetrafluoroethylene sutures.
Methods: From 1986 to 2004, 606 consecutive patients with degenerative mitral regurgitation had mitral valve
repair with chordal replacement with polytetrafluoroethylene sutures. Patients’ mean age was 57 years, and
73.6% were men. Isolated prolapse of the anterior leaflet was present in 17.6% of patients, isolated posterior
leaflet prolapse was present in 29.5% of patients, and bileaflet prolapse was present in 52.9% of patients. Pro-
lapse was corrected by creating 2 to 38 neochords of polytetrafluoroethylene sutures (mean, 13 9 per patient).
The mean follow-up was 10.1 years, and 96% of the patients had multiple echocardiographic studies over the
years.
Results: There were 5 early and 106 late deaths. Age, diabetes, hypertension, chronic obstructive lung disease,
New York Heart Association functional classes III and IV, and ejection fraction less than 40%were independent
predictors of mortality. At 18 years, freedom from reoperation on the mitral valve was 90.2% 2.4%, freedom
from recurrent severe mitral regurgitation was 91.0%  2.7%, and freedom from moderate or severe mitral
regurgitation was 67.5%  4.2%. Cox regression analysis revealed that isolated prolapse of the anterior leaflet
was predictive of reoperation, and that older age, hypertension, and left ventricular ejection fraction less than
40% were predictive of recurrent moderate or severe mitral regurgitation.
Conclusions: Chordal replacement with polytetrafluoroethylene sutures expands the indication of repair to pa-
tients with prolapse of multiple segments. Valve function remains stable in most patients during the first 2 de-
cades of follow-up. (J Thorac Cardiovasc Surg 2013;145:1563-9)A
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DChordal replacement during mitral valve (MV) repair
has been performed since the early days of cardiac surgery,
and materials such as silk, Teflon, nylon, strips of
autologous, and glutaraldehyde-fixed bovine pericardium
have been used.1-6 We first learned about the usefulness
of expanded polytetrafluoroethylene (ePTFE) sutures to
replace chordae tendineae at the Third International
Symposium on Cardiac Bioprosthesis. Herbert Vetter, then
a research fellow at Robert Frater’s laboratory, presented
‘‘Replacement of Chordae Tendineae of the Mitral Valve
Using the New Expanded PTFE Suture in Sheep.’’7 The re-
sults were impressive, and a few months later we began to
use ePTFE sutures to reinforce flimsy and elongated chordae
tendineae of the anterior leaflet of theMV that had been short-
ened during repair.8 As confidence in this material increased
and further experimental evidence of its safety and effective-
ness became available,9,10 we abandoned chordal shorteninge Division of Cardiovascular Surgery of Peter Munk Cardiac Centre, Toronto
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The Journal of Thoracic and Carand chordal transfer in favor of chordal replacement with
ePTFE sutures.11 The operative technique evolved fromusing
a single double-arm suture to replace each primary chorda by
securing it to the papillarymuscle and to the freemargin of the
leaflet, to creatingmultiple new chordswith a single suture by
successively passing once through the papillary muscle and
twice through the free margin of the leaflet in such way as
to have a neochord for every 2 to 3 mm of free margin of pro-
lapsing leaflet, and tying the ends of the suture on the papillary
muscle to leave the free margin free from the bulkiness of the
knots.11,12We have used ePTFE sutures to correct prolapse of
both anterior and posterior leaflets.13
This study examines our clinical experience with MV
repair using chordal replacement with ePTFE sutures dur-
ing the past 25 years.PATIENTS AND METHODS
The Research Ethics Board of the University Health Network approved
this study. From January 1986 to December 2004, 928 consecutive patients
underwent MV repair for mitral regurgitation (MR) due to degenerative
disease of the MV by the senior author. Chordal replacement with ePTFE
sutures was used in 606 of those patients. Table 1 shows the clinical char-
acteristics of these 606 patients. Patients with combined aortic valve/root
disease were included. Table 2 shows the operative data. The degree of
myxomatous changes in the leaflets was graded as mild, moderate, and ad-
vanced degeneration. It was defined as ‘‘mild’’ when the leaflets were thin
and had fairly normal sizes, and most segments were transparent except for
the prolapsing area. This grading included Carpentier’s ‘‘fibroelasticdiovascular Surgery c Volume 145, Number 6 1563
Abbreviations and Acronyms
CI ¼ confidence interval
ePTFE ¼ expanded polytetrafluoroethylene
HR ¼ hazard ratio
MR ¼ mitral regurgitation
MV ¼ mitral valve
POD ¼ postoperative day
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Ddeficiency’’ and cases with minimal myxomatous changes. Moderate de-
generation was defined when the leaflets were opaque as the result of ob-
vious myxomatous changes and the leaflet areas were increased but still
somewhat elastic and not excessively thick (<3 mm). Advanced degenera-
tion was definedwhen the leaflets were voluminous, aneurysmal, and thick-
ened (3 mm), and the annulus was massively dilated and often displayed
posterior displacement of 5 mm or more.14 The prolapse of the leaflets was
classified as anterior, posterior, or bileaflet. A few cases of isolated com-
missural prolapse were classified as bileaflet prolapse. Combined aortic
valve/root disease was present in 24 of 106 patients (22.6%) with isolated
anterior leaflet prolapse, 14 of 179 patients (7.8%) with isolated posterior
leaflet prolapse, and 26 of 321 patients (8.1%) with bileaflet prolapse
(P ¼ .0001).
Prolapse of the anterior leaflet and the commissural areas was
always corrected by chordal replacement with ePTFE sutures. Prolapse
of the posterior leaflet was corrected with ePTFE sutures when the leaflet
was normal in size or only slightly increased in height (eg,<20 mm) and
by partial resection when its height was 20 mm or more to shorten to ap-
proximately 15 mm. Patients with severe annular displacement had the
entire posterior leaflet detached from the annulus, shortened, and reat-
tached to the endocardium of the left ventricle where the annuloplasty su-
tures were applied.14 ePTFE chords were often needed to correct the
residual prolapse of this sliding plasty and reduction in posterior leaflet
height.
Prolapse of the leaflets was corrected by creating numerous new chords
of 5-0 or 6-0 ePTFE sutures between the papillary muscle and the free mar-
gin of the leaflet. An ePTFE suture was secured to the papillary muscle and
then successively passed twice through the free margin of the leaflet and
once through a fibrous portion of the papillary muscle to create 4 to 6 pairs
of chords per suture for a total of 8 to 12 neochords. Each chord was ap-
proximately 2 to 3 mm apart depending on the thickness of the leaflet at
the free margin to minimize the load in each one.15 Thus, a single suture
anchored 10 to 15 mm of the leaflet’s free margin. The length of each chord
was estimated on the basis of the coaptation level of a normal segment.
When every segment was prolapsing, we used the level of the mitral annu-
lus as the reference point in the arrested, relaxed heart. Because most neo-
chords were interdependent, final adjustment of length probably occurred
spontaneously after discontinuation of cardiopulmonary bypass. The num-
ber of neochords implanted ranged from 2 to 38, with a mean of 13  9
chords per repaired valve. Patients received warfarin sodium postopera-
tively for the first 3 postoperative months and permanently if they were
in atrial fibrillation.
Patients have been contacted every second year, and an echocardiogram
was obtained to assess valve and ventricular function. Approximately one
half of all echocardiograms were performed at outside institutions, and
their reports were entered into our database. The follow-up for this study
was closed on June 30, 2011. The mean follow-up was 10.1  4.5 years
(range, 0-23 years). All patients had at least 1 postoperative transthoracic
echocardiogram, and 96% of patients had multiple studies. The mean
echocardiographic study follow-up was 9.4  4.5 years (range, 0-22.6
years).1564 The Journal of Thoracic and Cardiovascular SurStatistical Analyses
All data analysis was performed using SAS software, version 9.2 for
Windows (SAS Institute, Inc, Cary, NC). Descriptive statistics were used
for continuous variables, including mean, median, standard deviation,
and standard error. Frequencies were used for categoric variables. Univar-
iate comparisons included unpaired t tests and analysis of variance for
continuous variables, contingency table analysis for categoric variables,
and Kaplan–Meir analysis for time-to-event outcomes. Cox multiple
regression analysis was performed to identify independent predictors of
time-to-event outcomes by entering all variables that had a univariate asso-
ciation with each outcome at P less than .25 or those of known clinical
significance but failing to meet the critical alpha level for submission to
the model. Variables entered included age per 5-year increment, female
gender, diabetes, hypertension, congestive heart failure, peripheral vascu-
lar disease, chronic obstructive lung disease, renal insufficiency, New
York Heart Association functional classes III and IV, left ventricular
dysfunction (ejection fraction<40%), coronary artery disease, degree of
myxomatous degeneration, leaflet prolapsed, concomitant aortic valve
surgery, aortic arch surgery, and urgent priority. The alpha for statistical
significance was 0.05.RESULTS
Operative Mortality and Morbidity
Five patients died in hospital, and autopsy was performed
in all 5. The causes of death were acute left ventricular
outflow tract obstruction caused by partial dehiscence of
the inflow suture of an aortic homograft in 1 patient on post-
operative day (POD) 1; acute type A dissection in 1 patient
on POD 6; volvulus with peritonitis, sepsis, and multiorgan
failure on POD 12 in 1 patient; ventricular fibrillation on
POD 7 after a perioperative myocardial infarction in 1
patient, and pneumonia at a convalescence hospital on
POD 51 in 1 patient. Two patients had perioperative myo-
cardial infarction, 4 patients had stroke, and 19 patients
had low cardiac output syndrome and required inotropes
(5 of them had an intra-aortic balloon pump). Early reoper-
ation was necessary for bleeding in 23 patients, cardiac tam-
ponade in 2 patients, cardiac arrest in 1 patient, sternal
infection in 1 patient, and MV re-repair for medically
intractable systolic anterior motion of the anterior leaflet
of the MV with MR in 1. Early postoperative atrial fibrilla-
tion occurred in 236 patients (39%).Late Mortality
Therewere 106 late deaths: valve- or cardiac-related in 52
patients, other causes in 53 patients, and unknown cause in 1
patient. The causes of valve- or cardiac-related deaths were
anticoagulation-related hemorrhage in 10 patients, stroke in
6 patients, congestive heart failure in 12 patients (due to
ventricular dysfunction in 9 and recurrent MR in 3), sudden
death in 12 patients, myocardial infarction in 9 patients,
after cardiac surgery for coronary artery disease in 1 patient,
aortic valve disease in 1 patient, and recurrent MR in 1
patient. Table 3 shows the variables predictive of mortality
from any cause by Cox regression analysis.gery c June 2013
TABLE 2. Operative data
Degree of myxomatous changes
None or mild 181 (29.8)
Moderate 248 (40.9)
Advanced 177 (29.2)
Mitral leaflet prolapse
AL prolapse 106 (17.4)
PL prolapse 179 (29.5)
Bileaflet prolapse 321 (52.9)
Mitral annuloplasty
None 32 (5.2)
Carpentier ring 52 (5.2)
Duran ring 116 (19.1)
Cosgrove band 406 (66.9)
Reconstruction of the mitral annulus 13 (3)
Tricuspid valve repair 22 (3.6)
Maze procedure for atrial fibrillation 17 (2.8)
Aortic valve repair  RAA 13 (2.1)
Aortic valve sparing 35 (5.7)
Bentall procedure 6 (1.0)
Aortic valve replacementþRAA 10 (1.6)
Coronary artery bypass 91 (15)
Cardiopulmonary bypass time (mean  SD) min 90  30
Aortic clamping time (mean  SD) min 72  25
Percentages are shown in parentheses. AL, Anterior leaflet; PL, posterior leaflet; RAA,
replacement of the ascending aorta; SD, standard deviation.
TABLE 1. Clinical characteristics of 606 patients
Age (mean  SD) 57.2  13.3 y
Range 18-88 y
Male sex 446 (73.6)
Electrocardiogram
Sinus rhythm 477 (78.6)
Atrial fibrillation 129 (21.3)
Associated diseases
Hypertension 161 (26.5)
Previous stroke 37 (6.1)
Diabetes 21 (3.4)
Peripheral vascular disease 3
Renal failure 4
COPD (FEV1<1 L/sec) 22 (3.6)
Remote infective endocarditis 56 (9.2)
Active infective endocarditis 2
NYHA functional class
1 and 2 331 (54.6)
3 and 4 275 (45.4)
LVEF
40% 570 (94)
<40% 36 (6)
Aortic valve/root disease 64 (10.5)
Tricuspid insufficiency>2þ 22 (3.6)
Coronary artery disease 91 (15.0)
Percentages are shown in parentheses. SD, Standard deviation; COPD, chronic ob-
structive pulmonary disease; FEV1, forced expiratory volume in 1 second; NYHA,
New York Heart Association; LVEF, left ventricular ejection fraction.
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DPatients’ Survival
Survival for all patients at 1, 10, and 18 years was 98.1%
 0.5%, 85.7%  1.5%, and 66.8%  3.3%, respec-
tively. Figure 1 shows Kaplan–Meier estimates of survival
of the entire cohort and of patients in New York Heart
Association functional classes 1 and 2 versus 3 and 4.Thromboembolic Complications
Thirty patients had 1 or more episodes of transient ische-
mic cerebral attacks, and 31 patients had a stroke (6 died).
The freedom from thromboembolic events at 1, 10, and
18 years was 96.8%  0.7%, 90.3%  0.9%, and
81.6%  3.6%, respectively.Endocarditis
Infective endocarditis developed in 5 patients; 2 required
reoperation, and 3 were treated with antibiotics alone. All
patients survived.
Reoperations. Reoperations on the MVwere performed in
35 patients. The indication for reoperation was recurrent
MR in 25 patients, hemolysis in 4 patients, mitral stenosis
in 3 patients (pannus in 2 and fibrosis and calcification of
the leaflets in 1), endocarditis in 2 patients, and systolic
anterior motion of the anterior leaflet of the MVin 1 patient.
The MV was replaced in 32 patients and re-repaired in 3
patients. Reoperations were performed 1 week to 22.6 yearsThe Journal of Thoracic and Carafter surgery. Reoperations were performed at Toronto
General Hospital in 33 patients with no operative mortality
and elsewhere in 2 patients with 1 death. A review of the
preoperative echocardiograms and operative reports on 33
patients who underwent operation at Toronto General Hos-
pital indicated that 2 patients had infective endocarditis
with destruction of the leaflets and the MV was replaced;
4 patients had hemolysis due to MR after complex MV re-
pair, including reconstruction of the mitral annulus because
of dystrophic calcification in 2 patients, and re-repair was
attempted but because there was residual MR, the MV
was replaced in all 4 patients; late mitral stenosis due to
pannus or calcification of the leaflets developed in 3
patients, and the MV was replaced; 1 patient had medically
intractable systolic anterior motion of the MV, and the MV
was re-repaired, and 23 patients had late MR that was due to
prolapse of 1 or more previously normal segments in 11
patients (9 had replacement and 2 had re-repair), fibrosis
and calcification of the anterior leaflet in 8 patients (all
had replacement), dehiscence of a rigid annuloplasty ring
and prolapse in 1 patient, ruptured papillary muscle due
to myocardial infarction in 1 patient, tethering of the leaflets
due to ventricular dysfunction and dilation in 1 patient, and
detachment of the ePTFE chords from papillary muscle in 1
patient (all 4 had replacement). In addition, the aortic valve
or root was replaced at the same time in 5 patients, and the
tricuspid valve was repaired in 4 patients. The only predic-
tor of reoperation by Cox regression analysis was isolateddiovascular Surgery c Volume 145, Number 6 1565
TABLE 3. Predictors of mortality (all causes) by Cox regression
analysis
Parameter HR 95% CI P value
Age by 5-y increments 1.40 1.26-1.56 .000
Diabetes 2.24 0.97-5.16 .058
Hypertension 1.60 1.09-2.35 .016
COPD 2.41 1.31-4.42 .004
NYHA class 3 and 4 2.02 1.28-3.19 .002
Ejection fraction<40% 4.57 2.70-7.74 .000
HR,Hazard ratio; CI, confidence interval; COPD, chronic obstructive pulmonary dis-
ease; NYHA, New York Heart Association.
FIGURE 2. Freedom from reoperation on the MV.
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Dprolapse of the anterior leaflet (hazard ratio [HR], 2.56;
95% confidence interval [CI], 0.99-6.63; P¼ .052). The de-
gree of myxomatous degeneration had no effect on the risk
of reoperation by multivariate analysis. The freedom from
reoperation on the MV at 1, 10, and 18 years was 98.6%
0.4%, 94.7% 0.9%, and 90.2%  2.4%, respec-
tively (Figure 2). The freedom from reoperation according
to which leaflet had prolapse is shown in Figure 3. In addi-
tion to the MV reoperations, 1 patient had coronary artery
bypass and 1 patient had aortic valve replacement, but noth-
ing was done to the MV because it was functioning
normally.
Recurrent mitral regurgitation. The latest echocardio-
gram before death, reoperation, or follow-up contact
showed that severe MR developed in 22 patients (10 under-
went reoperation, 8 died but only 1 ofMR, and 4 were alive)
and moderate MR developed in 60 patients (9 underwent re-
operation, 13 died but only 1 ofMR, and 38 were alive). The
following variables were predictive of recurrent moderate
or severe MR by Cox regression analysis: age by 5-year in-
crements (HR, 1.21; 95% CI, 1.10-1.34; P¼ .0001), hyper-
tension (HR, 1.82; 95% CI, 1.13-2.94; P ¼ .013), and left
ventricular ejection fraction less than 40% (HR, 4.72;
95% CI, 2.54-8.77; P ¼ .0001). Recurrent MR was moreFIGURE 1. Patients’ survival: Overall and according to functional class.
NYHA, New York Heart Association.
1566 The Journal of Thoracic and Cardiovascular Surcommon among patients with advanced myxomatous de-
generation, anterior leaflet prolapse, and bileaflet prolapse
by univariate analysis but not bymultivariate analysis. Free-
dom from severe MR at 1, 10, and 18 years was 100%,
96.5% 0.8%, and 91.0%  2.7%, respectively. Free-
dom from moderate or severe MR at 1, 10, and 18 years
was 98.5%  0.4%, 87.8%  1.5%, and 67.5% 
4.2%, respectively. Figure 4 shows the Kaplan–Meier esti-
mates of freedom from moderate or severe recurrent MR.Oral Anticoagulation
A total of 130 patients were taking an oral anticoagulant
at the time of latest follow-up: 20 for previous thromboem-
bolic event (stroke in 11 and transient ischemic attacks in 9)
and 58 for atrial dysrhythmias (fibrillation in 50 and flutter
in 8). In the remaining 52 patients, 12 had a permanent
pacemaker and 40 were in sinus rhythm. A total of 20 of
130 patients taking oral anticoagulation experienced major
bleeding, and 12 patients died.FIGURE 3. Freedom from reoperation on theMVaccording to leaflet pro-
lapse.
gery c June 2013
FIGURE 4. Freedom from recurrent moderate or severe MR. MR,Mitral
regurgitation.
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Electrocardiograms were available in 574 patients during
the follow-up; 416 were in sinus rhythm, 122 in atrial fibril-
lation or flutter, and 36 had paced beats.A
C
DFunctional Class
At the time of the latest follow-up contact, 462 patients
were alive with their native MV; 328 (71%) were in func-
tional class I, 94 (20.3%) were in class II, 39 (8.4%)
were in class III, and 1 (0.2%) was in class IV.DISCUSSION
ePTFE sutures are now frequently used to replace elon-
gated or ruptured chordae tendineae during MV repair
and to correct prolapse of the tricuspid valve leaflets due
to chordal elongation caused by degenerative disease or
papillary muscle rupture secondary to myocardial infarc-
tion or trauma. We initially used ePTFE suture to correct
prolapse of the anterior leaflet of the MV, but by 1990 we
began using it to repair prolapse of the posterior leaflet
and the commissures and progressively reduced use of
Carpentier’s techniques of leaflet resection, chordal short-
ening, and chordal transfer particularly in patients with nor-
mal or minimally enlarged leaflets, such as those with
fibroelastic deficiency or mild myxomatous changes.
Chordal replacement with ePTFE suture allowed us to in-
crease the MV repair rate to 95% of patients with MR
due to degenerative disease.13 We do not believe that there
is a contraindication to the use of ePTFE sutures to replace
chordae tendineae, and replacement of the MVis performed
only in older patients with advanced myxomatous degener-
ation of the entire valve with thickened and fibrotic leaflets.
Dystrophic calcification of themitral annulus is not a contra-
indication to MV repair if the leaflets are pliable. It isThe Journal of Thoracic and Carusually treated by resection of the calcium bar, reconstruc-
tion of the mitral annulus with pericardial substitutes, reat-
tachment of the posterior leaflet to the reconstructed
annulus, and correction of leaflet prolapse with neochords
of ePTFE.
Our operative technique of chordal replacement has
evolved over the years. We initially replaced each ruptured
or elongated primary chorda individually with a double-
arm 4-0 ePTFE suture by securing it to a fibrous portion of
the papillary muscle and then by passing it through the free
margin of the prolapsing leaflet and tying the ends together
on the ventricular side of the leaflet.8 As better understanding
of the biomechanical properties of ePTFE sutures became
known16 and our clinical experience increased, we began to
use larger number of neochords per centimeter of prolapsing
free margin to minimize the mechanical stress on each neo-
chord and on the leaflet where it was attached.12 This newer
approach allowed the repair of valves with prolapse of mul-
tiple segments and maintained a relatively low operative
time.14 During the past 15 years, only 6-0 and 5-0 ePTFE
sutures have been used for mitral and tricuspid valve repair.
As described in our previous publications,12-14 we first
secure the ePTFE suture on the papillary muscle; then the
longer arm of the suture is successively passed twice
through the free margin of the leaflet and once through
a fibrous portion of the papillary muscle and then back in
the free margin and so forth. The first and last loops of
neochord are usually attached to nonprolapsing segments
of the valve. A single suture is often used to create 4 to 6
pairs of neochords. Each neochord anchors only 2 to 3 mm
of free margin. This approach explains the relatively high
number of neochords we have used in our patients. We
have not documented neochord rupture but had 1 case of
detachment of the neochords from papillary muscle in our
experience with 33 patients who underwent reoperation at
Toronto General Hospital.
Although chordal replacement with ePTFE sutures is par-
ticularly useful in patients with prolapse of multiple seg-
ments, such as in advanced myxomatous degeneration of
the MV, it is also useful in patients with fibroelastic defi-
ciency with isolated prolapse of the posterior leaflet in
whom the leaflets are relatively normal and resection would
be associated with reduction of the MVorifice. We did not
perform mitral annuloplasty in 32 patients with fibroelastic
deficiency in whom the annulus was too small to be further
reduced and repair was accomplished by correcting the
leaflet prolapse alone. The current trend is to avoid leaflet
resection altogether and use only neochords to correct
leaflet prolapse.16-18 Some investigators believe that
a nonresectional approach during MV repair has less
deleterious effects on the movements of the mitral
annulus and on posterior leaflet mobility soon after
surgery.19 In our experience, flexible bands and ringsdiovascular Surgery c Volume 145, Number 6 1567
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Dbecome rigid within a few years after implantation. We fa-
vor posterior flexible bands over complete rings in patients
with normal ventricular function because that is where the
mitral annulus dilates in patients with degenerative
disease.20
Our patients who underwent MV repair with chordal re-
placement with ePTFE sutures do not represent a ‘‘general’’
population of patients with MR due to degenerative disease
because of referral bias and they underwent operation as
much as 25 years ago. Approximately one third of our pa-
tients had advanced myxomatous degeneration of the MV,
3% of patients had dystrophic calcification of the mitral an-
nulus, and only 29% of patients had isolated prolapse of the
posterior leaflet. In a recent report from Italy on chordal re-
placement with ePTFE sutures, more than one half of the
patients had isolated prolapse of the posterior leaflet.21 In
addition, we included patients who had aortic root or valve
operation. The proportion of patientswho had a concomitant
Maze procedure for atrial fibrillation was low largely be-
cause we did not routinely perform this procedure before
this millennium and most patients in this series underwent
operation before that. We also had a small number of pa-
tients who required concomitant tricuspid valve repair, al-
though we believe that moderate and severe tricuspid
regurgitation should be corrected at the time of MV surgery.
There is evidence that mild tricuspid regurgitation does not
need to be addressed at the time of MV repair for degener-
ative disease.22 The low incidence of tricuspid regurgitation
in our series could be explained by the fact that more than
one half of the patients were asymptomatic or had minimal
symptoms and underwent operation early in the course of
the MR.
The main purpose of the study was to examine the dura-
bility of MV repair when ePTFE was used to correct pro-
lapse of the leaflets. Although the freedom from
reoperation was low, recurrent MR after MV repair is com-
mon in patients with degenerative disease, particularly in
patients with isolated prolapse of the anterior leaflet. We
were surprised to find that the degree ofmyxomatous degen-
eration on the leaflets and the number of segments with pro-
lapse had no effect on the risk of reoperation or late
recurrent MR. This is possibly due to our liberal use of neo-
chords to anchor the prolapsing segments. However, this ap-
proach has not solved the problem of isolated anterior leaflet
prolapse, which was associated with a higher risk of reoper-
ation than with posterior or bileaflet prolapse. We could not
find a good explanation for the finding, but most patients
with recurrent MR and corrected prolapse of the anterior
leaflet had concomitant aortic valve disease. These patients
often have larger than normal anterior leaflets.23
The main indication for reoperation in our patients was
recurrent MR, but re-repair was feasible in only a few pa-
tients because the degenerative process progressed and the
leaflets became thickened, fibrotic, and sometimes even1568 The Journal of Thoracic and Cardiovascular Surcalcified in most patients who underwent reoperation. Sev-
eral patients were found to have severe or moderate recur-
rent MR at the time of last follow-up contact and are
being evaluated for reoperation. Although we do offer sur-
gery to asymptomatic patients with severe MR in whom
MV repair is likely, we tend to be more conservative in
thosewith asymptomatic recurrentMR because in our expe-
rience only a small proportion can undergo satisfactory re-
repair.Study Limitations
This is a retrospective, observational study of patients
who underwent MV repair with chordal replacement with
ePTFE sutures performed by a single surgeon, and the re-
sults may not be generalizable. The technique used to re-
place chordae tendineae changed during the study to
allow us to expand the indications of MV repair to patients
with more extensive leaflets prolapsed, and this may have
had adversely affected the durability of the repair. Approx-
imately one half of all follow-up echocardiograms were per-
formed at multiple institutions, and the interpretation of the
results may have been different if analyzed by a central lab-
oratory. Associated aortic valve disease also may have af-
fected the long-term outcomes, and the proportion was
too small for meaningful analysis.CONCLUSIONS
This study showed that chordal replacement with ePTFE
sutures allowed MV repair in patients with complex pathol-
ogies, such as advanced myxomatous degeneration with
prolapse of multiple segments. The long-term results are
satisfactory, but recurrent moderate or severe MR devel-
oped in approximately one third of the patients at 18 years
after surgery largely because of progression of the degener-
ative process.References
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